- Cutting-edge metagenomics
- Gut-microbiome-brain axis and autism
- Construction of gut microbiome biobanks
- Bacterial non-coding regulatory small RNAs
- Gut metabolome meets microbiome
- Genomic 3C-based genome mapping and positioning in gut microbiome
- Research on Microbes: from individual to population
- Synthetic ecology of the Human gut microbiota
- The ecotypes of Helicobacter pylori
- The human bactophagome
- The intercommunication between Shigella sonnei and E. coli. through type VI secretion system (T6SS)
- Skin microbiota analysis inspired development of new anti-infectives
- Virome and immune maturation
- Multi-center design to overcome the regional variation of disease microbiome signatures on the CALM platform
- Roles of gut microbes in the pathogenesis and development of obesity, NAFLD, and diabetes: a systems perspective
- Colonization barrier effect of the gut microbiota
- Defensins – a double-edged sword in host immunity?
- Bacteriocin-Gassericin-piglet diarrhea prevention
- Gut microbiota and modulation of immune response to flu
- SARS-Cov-2 infection and gut microbiota alterations
- Host micro biome interactions in health and disease
- Gut microbiome and metabolites in NAFLD and HCC
- Microorganisms and microbiome analysis in the gut - brain axis
- AI enabled microbiome data mining: methods and applications
- Deciphering the interplays in the gut jungle
- FMO3-TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction evidence from an Asian population
- Prevention and treatment effect of probiotics on colorectal cancer and its mechanism
- New mechanism of action of probiotics
- Bidirectional action of gut - brain axis and intestinal microecological management of cerebrovascular diseases
- Small molecule-mediated competition revealed by genome mining in the oral cavity
- Relationship between entero-hepatic axis and related diseases
- Discussion on the future direction of intestinal microecology from the perspective of high-level papers
Academic celebrities share the latest achievements
Promote the transformation and application of microbial therapy
Invite innovative enterprises and projects to build a bridge for investment and financing and project incubation
Professors, associate professors, researchers, associate researchers and technicians in scientific research institutes at home and abroad engaged in intestinal microbiology research
Clinicians in major hospitals at home and abroad, including chief physicians, deputy chief physicians and attending physicians in gastroenterology, oncology, laboratory and neurology
R & D personnel of domestic and foreign enterprises: personnel of microbial industry chain technology enterprises, including microbial culture, microbial sequencing, prebiotics, probiotics, microecological drug R & D, and microbiome big data analysis
Dear Mr./Ms.
You have registered successfully, the registration information and attention has been sent to the contact and the participants of the mailbox, please note that check. If not received, please contact the general meeting